MRK Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

119.360

Open

119.150

VWAP

117.74

Vol

7.39M

Mkt Cap

289.22B

Low

116.750

Amount

870.31M

EV/EBITDA(TTM)

10.81

Total Shares

2.47B

328.92B

EV/OCF(TTM)

19.97

P/S(TTM)

4.59

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Events Timeline

(ET)

2026-04-17

08:00:00

Merck's ENFLONSIA Approved by EU for RSV Prevention

2026-04-16 (ET)

2026-04-16

09:30:00

Senator Sanders Report Finds Prescription Drug Prices Continue to Rise

2026-04-13 (ET)

2026-04-13

07:10:00

Daiichi Sankyo and Merck's Drug Application Granted FDA Priority Review

2026-04-13

07:10:00

Daiichi Sankyo and Merck's Drug Application Accepted for Priority Review by FDA

2026-04-07 (ET)

2026-04-07

08:20:00

Evaxion Completes One-Year Extension of Phase 2 Trial for Personalized Cancer Vaccine EVX-01

News

9.0

04-20moomoo

PinnedMerck & Co Inc: FDA Establishes PDUFA Action Date for August 17, 2026

9.0

04-20moomoo

PinnedFDA Approves Priority Review for Keytruda® and Keytruda Qlex™ in Combination with Padcev® for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin

9.0

04-20seekingalpha

FDA Grants Priority Review for Pfizer and Astellas' Padcev with Keytruda for Bladder Cancer

9.0

04-20Newsfilter

KEYTRUDA and Padcev Combination Shows Significant Survival Benefits in Bladder Cancer

7.5

04-19Yahoo Finance

Recursion Pharmaceuticals Expands Partnership with Citeline to Enhance AI Drug Discovery

4.5

04-17Yahoo Finance

Health Care Stocks Rise 1.4% on NYSE

16 Analyst Rating

Wall Street analysts forecast MRK stock price to rise

11 Buy

5 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

95.00

Averages

119.53

High

139.00

Current: 0.000

Low

95.00

Averages

119.53

High

139.00

UBS

Michael Yee

Buy

maintain

$130 -> $145

AI Analysis

2026-04-13

Reason

UBS

Michael Yee

Price Target

$130 -> $145

AI Analysis

2026-04-13

maintain

Buy

Reason

UBS analyst Michael Yee raised the firm's price target on Merck to $145 from $130 and keeps a Buy rating on the shares. The firm adjusted targets in the pharmaceuticals and biotechnology group as part of a Q1 preview.

JPMorgan

Chris Schott

Overweight

maintain

$125 -> $135

2026-04-06

Reason

JPMorgan

Chris Schott

Price Target

$125 -> $135

2026-04-06

maintain

Overweight

Reason

JPMorgan analyst Chris Schott raised the firm's price target on Merck to $135 from $125 and keeps an Overweight rating on the shares ahead of the earnings report on April 30. The firm expects no major surprises in the quarter and sees the focus of the story remaining on Merck's pipeline. JPMorgan continues to see a favorable risk/return for the shares heading into the 2026 and 2027 data readouts.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MRK

Unlock Now

Valuation Metrics

The current forward P/E ratio for Merck & Co Inc (MRK.N) is 23.31, compared to its 5-year average forward P/E of 16.73. For a more detailed relative valuation and DCF analysis to assess Merck & Co Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

16.73

Current PE

23.31

Overvalued PE

31.61

Undervalued PE

1.84

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

11.53

Current EV/EBITDA

11.46

Overvalued EV/EBITDA

16.57

Undervalued EV/EBITDA

6.49

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

4.07

Current PS

4.20

Overvalued PS

4.66

Undervalued PS

3.48

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

Swing Trading

Intellectia · 79 candidates

Price: $5.00 - $150.00List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Support Resistance Relationship: PriceAroundSupportMonthly Average Dollar Volume: >= 500,000

Ticker

Name

Market Cap$

WBD

Warner Bros Discovery Inc

68.86B

MRK

Merck & Co Inc

294.09B

HAL

Halliburton Co

31.03B

Coca-Cola Co

326.00B

FSLY

Fastly Inc

3.73B

BKR

Baker Hughes Co

59.29B

technical analysis on to buy or sell?

Intellectia · 7 candidates

Rsi Category: moderateMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Month Price Change Pct: >= $0.00Is Index Component: DJIMacd: positive, bullish

Ticker

Name

Market Cap$

UNH

UnitedHealth Group Inc

255.38B

CSCO

Cisco Systems Inc

317.71B

Goldman Sachs Group Inc

255.48B

JPM

JPMorgan Chase & Co

796.84B

MRK

Merck & Co Inc

298.79B

AXP

American Express Co

209.66B

which stock is the best to buy right now

Intellectia · 35 candidates

Market Cap: >= 30.00BNet Margin: >= 10.00Eps 5yr Cagr: >= 10Pe Ttm: 12 - 25Moving Average Relationship: PriceAboveMA20, PriceAboveMA200

Ticker

Name

Market Cap$

Anglogold Ashanti PLC

51.18B

AXP

American Express Co

205.86B

PNC

PNC Financial Services Group Inc

85.39B

Chubb Limited

128.41B

Bank of New York Mellon Corp

84.05B

FITB

Fifth Third Bancorp

42.66B

What should I put my money on?

Intellectia · 37 candidates

Market Cap: >= 50.00BAnalyst Consensus: Strong Buy, Moderate BuyEps Ttm: >= 0Beta: LowRisk, ModerateRiskRevenue 5yr Cagr: >= 8Pe Ttm: 10 - 25

Ticker

Name

Market Cap$

MSFT

Microsoft Corp

2.77T

BRK.B

Berkshire Hathaway Inc

1.03T

JPM

JPMorgan Chase & Co

794.55B

XOM

Exxon Mobil Corp

669.56B

MRK

Merck & Co Inc

298.84B

Morgan Stanley

263.28B

what are some decent stocks to buy rn

Intellectia · 54 candidates

Market Cap: >= 30.00BPe Ttm: 10 - 30List Exchange: XNYS, XNAS, XASEReturn On Equity: >= 15.0%Moving Average Relationship: PriceAboveMA200

Ticker

Name

Market Cap$

TSM

Taiwan Semiconductor Manufacturing Co Ltd

1.69T

JNJ

Johnson & Johnson

579.15B

Micron Technology Inc

402.85B

Coca-Cola Co

325.87B

CSCO

Cisco Systems Inc

315.68B

MRK

Merck & Co Inc

295.77B

nyse

Intellectia · 48 candidates

Market Cap: >= 30.00BMarket Cap Category: large, megaRevenue 5yr Cagr: >= 8Pe Ttm: 10 - 25List Exchange: XNYSReturn On Equity: >= 12.0%

Ticker

Name

Market Cap$

JPM

JPMorgan Chase & Co

762.83B

MRK

Merck & Co Inc

295.77B

Morgan Stanley

251.50B

Goldman Sachs Group Inc

236.85B

UNH

UnitedHealth Group Inc

235.11B

Royal Bank of Canada

220.86B

best stock buy right now

Intellectia · 23 candidates

Eps 5yr Cagr: >= 10Pe Ttm: 10 - 35Return On Equity: >= 15.0%Moving Average Relationship: PriceAboveMA200Is Index Component: GSPC, NDXOne Month Predict Return: >= 0.0%

Ticker

Name

Market Cap$

BALL

Ball Corp

15.87B

FDX

FedEx Corp

83.40B

MRK

Merck & Co Inc

294.04B

AMAT

Applied Materials Inc

268.68B

SNA

Snap-On Inc

18.84B

ETN

Eaton Corporation PLC

138.55B

top stocks in health sector

Intellectia · 38 candidates

Market Cap: >= 10.00BSector: Healthcare, Healthcare Services & EquipmentIndustry: Biotechnology & Medical Research, Healthcare Equipment & Supplies, Healthcare Providers & Services, PharmaceuticalsAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 5List Exchange: XNYS, XNAS, XASEReturn On Equity: >= 10.0%

Ticker

Name

Market Cap$

LLY

Eli Lilly and Co

866.87B

ABBV

AbbVie Inc

364.65B

AZN

AstraZeneca PLC

293.00B

MRK

Merck & Co Inc

282.35B

UNH

UnitedHealth Group Inc

254.55B

AMGN

Amgen Inc

188.63B

Best place to in vest $10,000.00

Intellectia · 81 candidates

Market Cap: >= 20.00BRegion: USNet Margin: >= 10.00Revenue 5yr Cagr: >= 5Pe Ttm: 10 - 30List Exchange: XNYS, XNAS, XASEIs Index Component: GSPC

Ticker

Name

Market Cap$

Whales Holding MRK

Distillate Capital Partners LLC

Bank J. Safra Sarasin AG

Arrowstreet Capital, Limited Partnership

Ofi Invest Asset Management

Numeric Investors LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Merck & Co Inc (MRK) stock price today?

The current price of MRK is 117.1 USD — it has decreased -1.65

What is Merck & Co Inc (MRK)'s business?

What is the price predicton of MRK Stock?

Wall Street analysts forecast MRK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MRK is119.53 USD with a low forecast of 95.00 USD and a high forecast of 139.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Merck & Co Inc (MRK)'s revenue for the last quarter?

Merck & Co Inc revenue for the last quarter amounts to 16.40B USD, increased 4.97

What is Merck & Co Inc (MRK)'s earnings per share (EPS) for the last quarter?

Merck & Co Inc. EPS for the last quarter amounts to 1.19 USD, decreased -19.59

How many employees does Merck & Co Inc (MRK). have?

Merck & Co Inc (MRK) has 75000 emplpoyees as of April 21 2026.

What is Merck & Co Inc (MRK) market cap?

Today MRK has the market capitalization of 289.22B USD.

MRK Overview

MRK Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding MRK

Trading Trends

People Also Watch

Frequently Asked Questions

What is Merck & Co Inc (MRK) stock price today?

What is Merck & Co Inc (MRK)'s business?

What is the price predicton of MRK Stock?

What is Merck & Co Inc (MRK)'s revenue for the last quarter?

What is Merck & Co Inc (MRK)'s earnings per share (EPS) for the last quarter?

How many employees does Merck & Co Inc (MRK). have?

What is Merck & Co Inc (MRK) market cap?